Related Experiment Video
Updated: Apr 23, 2026

Anionic Polymerization of an Amphiphilic Copolymer for Preparation of Block Copolymer Micelles Stabilized by π-π Stacking Interactions
Published on: October 10, 2016
Doxycycline and oxytetracycline loading of a zwitterionic amphoteric surfactant-gel and their controlled release
A Cesaretti1, B Carlotti, P L Gentili
1Department of Chemistry, Biology and Biotechnology and Centre of Excellence on Nanostructured Innovative Materials (CEMIN), University of Perugia, via Elce di Sotto 8, 06123 Perugia, Italy. fausto.elisei@unipg.it.
Abstract:
Oxytetracycline (OX) and doxycycline (DX) are antibiotics belonging to the family of tetracyclines. We present a UV-Visible steady state and time-resolved experimental study of OX and DX and their biologically active Mg(2+) complexes loaded within a hydrogel matrix. Hydrogels are a three dimensional network of worm-like micelles, mutually intertwined, forming a pattern of hydrophobic domains and water pools. We resorted to a hydrogel, made of a zwitterionic N-oxide surfactant (p-dodecyloxybenzyldimethylamine N-oxide, pDoAO), which showed promising features as a drug vehicle. The spectral and photophysical properties of the drugs are significantly altered by the inclusion in the hydrophobic domains of the gel and these variations are indicators of the permeation ratio of the drug in between the micelles forming the gel network. We thus get a clear picture of the distribution of the drug molecules and metal chelates into the two different kinds of environment, where the hydrophobic domains are also able to cause a gel-induced deprotonation of these two drugs. Furthermore, the amphoteric nature of the surfactant is responsible for its peculiar acid-base behaviour: under acidic pH conditions, the surfactant gets protonated and the stability of the gel network is damaged. This feature can be thus exploited for the pH controlled release of the tetracycline drugs.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Oral Drug Delivery Systems: Continuous-Release Systems
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-Release Drug Delivery Systems: Rate-Programmed I

